| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.23 | 0.08 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |